Weinberg V - Search Results

1

Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.

Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F. Rauen KA, et al. Among authors: weinberg v. Cancer Res. 2002 Jul 1;62(13):3812-8. Cancer Res. 2002. PMID: 12097294

2

Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer.

Watson JE, Doggett NA, Albertson DG, Andaya A, Chinnaiyan A, van Dekken H, Ginzinger D, Haqq C, James K, Kamkar S, Kowbel D, Pinkel D, Schmitt L, Simko JP, Volik S, Weinberg VK, Paris PL, Collins C. Watson JE, et al. Oncogene. 2004 Apr 22;23(19):3487-94. doi: 10.1038/sj.onc.1207474. Oncogene. 2004. PMID: 15007382

3

Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.

Rini BI, Jaeger E, Weinberg V, Sein N, Chew K, Fong K, Simko J, Small EJ, Waldman FM. Rini BI, et al. Among authors: weinberg v. BJU Int. 2006 Oct;98(4):756-62. doi: 10.1111/j.1464-410X.2006.06376.x. Epub 2006 Jul 7. BJU Int. 2006. PMID: 16827904

4

Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.

Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD. Meng MV, et al. Among authors: weinberg v. Clin Cancer Res. 2001 Sep;7(9):2712-8. Clin Cancer Res. 2001. PMID: 11555583 Free article.

5

Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.

Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID. Ryan CJ, et al. Among authors: weinberg v. Urol Oncol. 2007 Mar-Apr;25(2):134-40. doi: 10.1016/j.urolonc.2006.07.019. Urol Oncol. 2007. PMID: 17349528

6

Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?

Roach M 3rd, Weinberg V, Sandler H, Thompson I. Roach M 3rd, et al. Among authors: weinberg v. Cancer. 2007 Jan 15;109(2):213-20. doi: 10.1002/cncr.22403. Cancer. 2007. PMID: 17167758 Free article.

7

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium.

Harzstark AL, Rosenberg JE, Weinberg VK, Sharib J, Ryan CJ, Smith DC, Pagliaro LC, Beer TM, Liu G, Small EJ. Harzstark AL, et al. Cancer. 2011 Jun 1;117(11):2419-25. doi: 10.1002/cncr.25810. Epub 2010 Dec 29. Cancer. 2011. PMID: 24048789 Free article. Clinical Trial.

8

A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy.

Rosenberg JE, Galsky MD, Rohs NC, Weinberg VK, Oh WK, Kelly WK, Small EJ. Rosenberg JE, et al. Cancer. 2006 Jan 1;106(1):58-62. doi: 10.1002/cncr.21559. Cancer. 2006. PMID: 16329138 Free article.

9

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma.

Rini BI, Weinberg V, Shaw V, Scott J, Bok R, Park JW, Small EJ. Rini BI, et al. Among authors: weinberg v. Cancer. 2004 Jul 1;101(1):90-5. doi: 10.1002/cncr.20313. Cancer. 2004. PMID: 15221993 Free article. Clinical Trial.

10

Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.

Wang VE, Blaser BW, Patel RK, Behbehani GK, Rao AA, Durbin-Johnson B, Jiang T, Logan AC, Settles M, Mannis GN, Olin R, Damon LE, Martin TG, Sayre PH, Gaensler KM, McMahon E, Flanders M, Weinberg V, Ye CJ, Carbone DP, Munster PN, Fragiadakis GK, McCormick F, Andreadis C. Wang VE, et al. Among authors: weinberg v. Blood Cancer Discov. 2021 Sep;2(5):434-449. doi: 10.1158/2643-3230.BCD-21-0055. Epub 2021 Jul 16. Blood Cancer Discov. 2021. PMID: 34514432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters